Literature DB >> 15076008

Prophylaxis of iodinated contrast media-induced nephropathy: a pharmacological point of view.

Jean-Marc Idé1, Eric Lancelot, Emmanuelle Pines, Claire Corot.   

Abstract

Iodinated contrast media are a frequent cause of acute renal failure, especially in patients whose renal function is already impaired. In addition to hydration, which remains the most commonly acknowledged means of protection, numerous pharmacological approaches for the prophylaxis of contrast nephropathy have been tested so far. They include diuretics, calcium channel blockers, adenosine receptor antagonists, N-acetylcysteine, low-dose dopamine and the dopamine D1 receptor agonist fenoldopam, endothelin receptor antagonists, and even captopril. The present review of the literature critically discusses the drugs used to prevent contrast nephropathy from a pharmacological point of view.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15076008     DOI: 10.1097/01.rli.0000101483.60710.2c

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  7 in total

Review 1.  How to protect from contrast media-induced nephropathy?

Authors:  B Scheller
Journal:  Clin Res Cardiol       Date:  2007-03       Impact factor: 5.460

2.  Delivery of recombinant adeno-associated virus-mediated human tissue kallikrein for therapy of chronic renal failure in rats.

Authors:  Ling Tu; Xizhen Xu; Huaibing Wan; Changqing Zhou; Juanjuan Deng; Gang Xu; Xiao Xiao; Yipu Chen; Matthew L Edin; James W Voltz; Darryl C Zeldin; Dao Wen Wang
Journal:  Hum Gene Ther       Date:  2008-04       Impact factor: 5.695

Review 3.  X-ray-computed tomography contrast agents.

Authors:  Hrvoje Lusic; Mark W Grinstaff
Journal:  Chem Rev       Date:  2012-12-05       Impact factor: 60.622

4.  Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT.

Authors:  Martin Zo'o; Marcus Hoermann; Csilla Balassy; Francis Brunelle; Robin Azoulay; Danièle Pariente; Michel Panuel; Patrick Le Dosseur
Journal:  Pediatr Radiol       Date:  2011-06-29

5.  Short term high dose atorvastatin for the prevention of contrast-induced nephropathy in patients undergoing computed tomography angiography.

Authors:  Hamid Sanei; Alireza Hajian-Nejad; Amirreza Sajjadieh-Kajouei; Neda Nazemzadeh; Nehzat Alizadeh; Peyman Bidram; Behrouz Pourheidar
Journal:  ARYA Atheroscler       Date:  2014-09

6.  Synthesis, characterization, and X-ray attenuation properties of ultrasmall BiOI nanoparticles: toward renal clearable particulate CT contrast agents.

Authors:  Murthi S Kandanapitiye; Min Gao; Joseph Molter; Chris A Flask; Songping D Huang
Journal:  Inorg Chem       Date:  2014-09-09       Impact factor: 5.165

7.  Sodium Bicarbonate Prevents Contrast-Induced Nephropathy in Addition to Theophylline: A Randomized Controlled Trial.

Authors:  Wolfgang Huber; Toni Huber; Stephan Baum; Michael Franzen; Christian Schmidt; Thomas Stadlbauer; Analena Beitz; Roland M Schmid; Sebastian Schmid
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.